Investor · NEW YORK, NY
Jeremy D. Lack
Open Jeremy in the network graph →Filings
37
SEC Form D
Connections
121
co-filers
Capital
$1.8B
across filings
Active
May 2014
to Jan 2019
Most-connected co-filers (121)
Paul A. Wakefield · NEW YORK, NY24 sharedAndrew C. Hyman · NEW YORK, NY22 sharedJeffrey A. Ferrell · NEW YORK, NY17 sharedCourtney C. Paul · NEW YORK, NY16 sharedElin C. Strong · NEW YORK, NY14 sharedDavid J. Helfet · Palm Beach Gardens, FL9 sharedMichael Lobatz · Carlsbad, CA9 sharedDeven S. Clemens · Emeryville, CA9 sharedStuart Medlen · New York, NY9 sharedErin N. Ruhe · Carlsbad, CA9 sharedMark B. Kanter · CALABASAS, CA9 sharedAlbert-Oliver M. Drouart · Hermosa Beach, CA8 sharedBrian Katz · McLean, VA8 sharedKlas M. Back · Hermosa Beach, CA8 sharedKartheek Mulpuri · Fairfax Station, VA8 sharedKeith Kulow · Norfolk, VA8 sharedJack M. Mans · San Francisco, CA8 sharedNicholas Parkes · Luxembourg, Luxembourg8 sharedEric M. Brubaker · San Francisco, CA8 sharedClaude Grunitzky · New York, NY8 sharedLou Malice · CARLSBAD, CA8 sharedDarren N. Gorman · Luxembourg, Luxembourg8 sharedBrian Friedman · Carlsbad, CA8 sharedDavid Redmond · Naperville, IL8 shared
Recent filings (37)
Athyrium Opportunities Fund IV (Non-US) LPDec 2021 · 20 co-filersAthyrium Opportunities Fund IV LPDec 2021 · 20 co-filersAthyrium Opportunities Fund IV Master (Non-US) LPDec 2021 · 20 co-filersHyalex Orthopaedics, Inc.Jul 2021 · 19 co-filers$34.9MAthyrium Healthcare Strategic Income & Growth IDF LLCJan 2021 · 20 co-filersAthyrium Opportunities Fund IV Master (Non-US) LPDec 2020 · 20 co-filersAthyrium Opportunities Fund IV (Non-US) LPDec 2020 · 20 co-filersAthyrium Opportunities Fund IV LPDec 2020 · 20 co-filersAthyrium Healthcare Strategic Income & Growth IDF LLCJan 2020 · 17 co-filersNavigating Cancer, Inc.Sep 2019 · 14 co-filers$26.0MNavigating Cancer, Inc.May 2019 · 25 co-filers$353KHyalex Orthopaedics, Inc.Mar 2019 · 19 co-filers$33.0MNavigating Cancer, Inc.Mar 2019 · 23 co-filers$20.0MAthyrium Healthcare Strategic Income & Growth IDF LLCJan 2019 · 16 co-filersTRILOGY INVESTMENT FUND PLC - THE VALANT SERIES EMERGING MARKETS FUNDJul 2018 · 8 co-filersAthyrium Healthcare Strategic Income & Growth IDF LLCFeb 2018 · 16 co-filersTRILOGY INVESTMENT FUND PLC - THE VALANT SERIES EMERGING MARKETS FUNDJul 2017 · 6 co-filersAthyrium Healthcare Strategic Income & Growth IDF LLCFeb 2017 · 16 co-filersAthyrium Opportunities Fund III LPNov 2016 · 16 co-filersAthyrium Opportunities Fund III (Non-US) B LPNov 2016 · 16 co-filersAthyrium Opportunities Fund III (Non-US) A LPNov 2016 · 16 co-filersAlcresta Therapeutics, Inc.Oct 2016 · 27 co-filers$50.9MMarcato Encore International Ltd.Jul 2016 · 9 co-filersTRILOGY INVESTMENT FUND PLC - THE VALANT SERIES EMERGING MARKETS FUNDJul 2016 · 10 co-filersMarcato Encore, L.P.Jul 2016 · 6 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jeremy in the interactive graph →